Core Laboratories N.V. (NYSE: CLB) reported Q1 EPS of $1.45, in-line with the analyst estimate of $1.45. Revenue for the quarter came in at $262.9 million versus the consensus estimate of $283.02 million.

Core Laboratories N.V. sees FY2014 EPS of $6.00-$6.25, versus the consensus of $6.21. Core Laboratories N.V. sees FY2014 revenue of $1.115-1.175 billion, versus the consensus of $1.18 billion.

Core Laboratories N.V. sees Q2 2014 EPS of $1.48-$1.53, versus the consensus of $1.53. Core Laboratories N.V. sees Q2 2014 revenue of $280-286 million, versus the consensus of $289.8 million.

For earnings history and earnings-related data on Core Laboratories N.V. (CLB) click here.